1	Three	_	NUM	CD	_	4	num	_	_
2	leading	_	VERB	VBG	_	4	amod	_	_
3	drug	_	NOUN	NN	_	4	nn	_	_
4	companies	_	NOUN	NNS	_	5	nsubj	_	_
5	reported	_	VERB	VBD	_	0	root	_	_
6	robust	_	ADJ	JJ	_	8	amod	_	_
7	third-quarter	_	NOUN	NN	_	8	nn	_	_
8	earnings	_	NOUN	NNS	_	5	dobj	_	_
9	,	_	PUNCT	,	_	8	punct	_	_
10	bolstered	_	VERB	VBN	_	8	vmod	_	_
11	by	_	ADP	IN	_	10	prep	_	_
12	strong	_	ADJ	JJ	_	13	amod	_	_
13	sales	_	NOUN	NNS	_	11	pobj	_	_
14	of	_	ADP	IN	_	13	prep	_	_
15	newer	_	ADJ	JJR	_	19	amod	_	_
16	,	_	PUNCT	,	_	19	punct	_	_
17	big-selling	_	ADJ	JJ	_	19	amod	_	_
18	prescriptions	_	NOUN	NNS	_	19	nn	_	_
19	drugs	_	NOUN	NNS	_	14	pobj	_	_
20	that	_	PRON	WDT	_	21	nsubj	_	_
21	provide	_	VERB	VBP	_	19	rcmod	_	_
22	hefty	_	ADJ	JJ	_	24	amod	_	_
23	profit	_	NOUN	NN	_	24	nn	_	_
24	margins	_	NOUN	NNS	_	21	dobj	_	_
25	.	_	PUNCT	.	_	5	punct	_	_

1	Merck	_	PROPN	NNP	_	4	nsubj	_	_
2	&	_	CONJ	CC	_	1	cc	_	_
3	Co.	_	PROPN	NNP	_	1	conj	_	_
4	reported	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	8	det	_	_
6	25	_	NUM	CD	_	7	number	_	_
7	%	_	SYM	NN	_	8	amod	_	_
8	increase	_	NOUN	NN	_	4	dobj	_	_
9	in	_	ADP	IN	_	8	prep	_	_
10	earnings	_	NOUN	NNS	_	9	pobj	_	_
11	;	_	PUNCT	:	_	4	punct	_	_
12	Warner-Lambert	_	PROPN	NNP	_	13	nn	_	_
13	Co.	_	PROPN	NNP	_	15	poss	_	_
14	's	_	PART	POS	_	13	possessive	_	_
15	profit	_	NOUN	NN	_	16	nsubj	_	_
16	rose	_	VERB	VBD	_	4	parataxis	_	_
17	22	_	NUM	CD	_	18	num	_	_
18	%	_	SYM	NN	_	16	dobj	_	_
19	and	_	CONJ	CC	_	16	cc	_	_
20	Eli	_	PROPN	NNP	_	21	nn	_	_
21	Lilly	_	PROPN	NNP	_	26	poss	_	_
22	&	_	CONJ	CC	_	21	cc	_	_
23	Co.	_	PROPN	NNP	_	21	conj	_	_
24	's	_	PART	POS	_	23	possessive	_	_
25	net	_	ADJ	JJ	_	26	amod	_	_
26	income	_	NOUN	NN	_	27	nsubj	_	_
27	rose	_	VERB	VBD	_	16	conj	_	_
28	24	_	NUM	CD	_	29	num	_	_
29	%	_	SYM	NN	_	27	dobj	_	_
30	.	_	PUNCT	.	_	4	punct	_	_

1	The	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	3	nsubj	_	_
3	were	_	VERB	VBD	_	0	root	_	_
4	in	_	ADP	IN	_	3	prep	_	_
5	line	_	NOUN	NN	_	4	pobj	_	_
6	with	_	ADP	IN	_	5	prep	_	_
7	analysts	_	NOUN	NNS	_	9	poss	_	_
8	'	_	PART	POS	_	7	possessive	_	_
9	expectations	_	NOUN	NNS	_	6	pobj	_	_
10	.	_	PUNCT	.	_	3	punct	_	_

1	Merck	_	PROPN	NNP	_	0	root	_	_
2	&	_	CONJ	CC	_	1	cc	_	_
3	Co	_	PROPN	NNP	_	1	conj	_	_
4	.	_	PUNCT	.	_	1	punct	_	_

1	Merck	_	PROPN	NNP	_	7	nsubj	_	_
2	,	_	PUNCT	,	_	1	punct	_	_
3	Rahway	_	PROPN	NNP	_	1	appos	_	_
4	,	_	PUNCT	,	_	3	punct	_	_
5	N.J.	_	PROPN	NNP	_	3	appos	_	_
6	,	_	PUNCT	,	_	1	punct	_	_
7	continued	_	VERB	VBD	_	0	root	_	_
8	to	_	PART	TO	_	9	aux	_	_
9	lead	_	VERB	VB	_	7	xcomp	_	_
10	the	_	DET	DT	_	11	det	_	_
11	industry	_	NOUN	NN	_	9	dobj	_	_
12	with	_	ADP	IN	_	9	prep	_	_
13	a	_	DET	DT	_	16	det	_	_
14	strong	_	ADJ	JJ	_	16	amod	_	_
15	sales	_	NOUN	NNS	_	16	nn	_	_
16	performance	_	NOUN	NN	_	12	pobj	_	_
17	in	_	ADP	IN	_	16	prep	_	_
18	the	_	DET	DT	_	19	det	_	_
19	human	_	NOUN	NN	_	17	pobj	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	animal	_	NOUN	NN	_	23	nn	_	_
22	health-products	_	NOUN	NNS	_	23	nn	_	_
23	segment	_	NOUN	NN	_	19	conj	_	_
24	.	_	PUNCT	.	_	7	punct	_	_

1	A	_	DET	DT	_	4	det	_	_
2	stronger	_	ADJ	JJR	_	4	amod	_	_
3	U.S.	_	PROPN	NNP	_	4	nn	_	_
4	dollar	_	NOUN	NN	_	5	nsubj	_	_
5	reduced	_	VERB	VBD	_	0	root	_	_
6	third-quarter	_	NOUN	NN	_	10	nn	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	first-nine-month	_	ADJ	JJ	_	6	conj	_	_
9	sales	_	NOUN	NNS	_	10	nn	_	_
10	growth	_	NOUN	NN	_	5	iobj	_	_
11	2	_	NUM	CD	_	12	num	_	_
12	%	_	SYM	NN	_	5	dobj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	3	_	NUM	CD	_	15	num	_	_
15	%	_	SYM	NN	_	12	conj	_	_
16	,	_	PUNCT	,	_	12	punct	_	_
17	respectively	_	ADV	RB	_	12	advmod	_	_
18	.	_	PUNCT	.	_	5	punct	_	_

1	International	_	ADJ	JJ	_	2	amod	_	_
2	sales	_	NOUN	NNS	_	3	nsubj	_	_
3	accounted	_	VERB	VBD	_	0	root	_	_
4	for	_	ADP	IN	_	3	prep	_	_
5	47	_	NUM	CD	_	6	num	_	_
6	%	_	SYM	NN	_	4	pobj	_	_
7	of	_	ADP	IN	_	6	prep	_	_
8	total	_	ADJ	JJ	_	10	amod	_	_
9	company	_	NOUN	NN	_	10	nn	_	_
10	sales	_	NOUN	NNS	_	7	pobj	_	_
11	for	_	ADP	IN	_	10	prep	_	_
12	the	_	DET	DT	_	14	det	_	_
13	nine	_	NUM	CD	_	14	num	_	_
14	months	_	NOUN	NNS	_	11	pobj	_	_
15	,	_	PUNCT	,	_	3	punct	_	_
16	compared	_	VERB	VBN	_	3	prep	_	_
17	with	_	ADP	IN	_	16	pcomp	_	_
18	50	_	NUM	CD	_	19	num	_	_
19	%	_	SYM	NN	_	17	pobj	_	_
20	a	_	DET	DT	_	21	det	_	_
21	year	_	NOUN	NN	_	22	npadvmod	_	_
22	earlier	_	ADV	RBR	_	17	advmod	_	_
23	.	_	PUNCT	.	_	3	punct	_	_

1	Sales	_	NOUN	NNS	_	5	nsubj	_	_
2	for	_	ADP	IN	_	1	prep	_	_
3	the	_	DET	DT	_	4	det	_	_
4	quarter	_	NOUN	NN	_	2	pobj	_	_
5	rose	_	VERB	VBD	_	0	root	_	_
6	to	_	ADP	TO	_	5	prep	_	_
7	$	_	SYM	$	_	6	pobj	_	_
8	1.63	_	NUM	CD	_	9	number	_	_
9	billion	_	NUM	CD	_	7	num	_	_
10	from	_	ADP	IN	_	5	prep	_	_
11	$	_	SYM	$	_	10	pobj	_	_
12	1.47	_	NUM	CD	_	13	number	_	_
13	billion	_	NUM	CD	_	11	num	_	_
14	.	_	PUNCT	.	_	5	punct	_	_

1	Mevacor	_	PROPN	NNP	_	9	nsubj	_	_
2	,	_	PUNCT	,	_	1	punct	_	_
3	Merck	_	PROPN	NNP	_	7	poss	_	_
4	's	_	PART	POS	_	3	possessive	_	_
5	new	_	ADJ	JJ	_	7	amod	_	_
6	cholesterol-lowering	_	ADJ	JJ	_	7	amod	_	_
7	drug	_	NOUN	NN	_	1	appos	_	_
8	,	_	PUNCT	,	_	1	punct	_	_
9	had	_	VERB	VBD	_	31	ccomp	_	_
10	higher	_	ADJ	JJR	_	11	amod	_	_
11	sales	_	NOUN	NNS	_	9	dobj	_	_
12	than	_	SCONJ	IN	_	19	mark	_	_
13	any	_	DET	DT	_	16	det	_	_
14	other	_	ADJ	JJ	_	16	amod	_	_
15	prescription	_	NOUN	NN	_	16	nn	_	_
16	medicine	_	NOUN	NN	_	19	nsubj	_	_
17	has	_	AUX	VBZ	_	19	aux	_	_
18	ever	_	ADV	RB	_	19	advmod	_	_
19	achieved	_	VERB	VBN	_	11	advcl	_	_
20	in	_	ADP	IN	_	19	prep	_	_
21	the	_	DET	DT	_	22	det	_	_
22	U.S.	_	PROPN	NNP	_	20	pobj	_	_
23	in	_	ADP	IN	_	19	prep	_	_
24	the	_	DET	DT	_	25	det	_	_
25	year	_	NOUN	NN	_	23	pobj	_	_
26	following	_	VERB	VBG	_	25	prep	_	_
27	introduction	_	NOUN	NN	_	26	pobj	_	_
28	,	_	PUNCT	,	_	31	punct	_	_
29	the	_	DET	DT	_	30	det	_	_
30	company	_	NOUN	NN	_	31	nsubj	_	_
31	said	_	VERB	VBD	_	0	root	_	_
32	.	_	PUNCT	.	_	31	punct	_	_

1	The	_	DET	DT	_	2	det	_	_
2	drug	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	AUX	VBD	_	4	auxpass	_	_
4	introduced	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	4	prep	_	_
6	West	_	PROPN	NNP	_	7	nn	_	_
7	Germany	_	PROPN	NNP	_	5	pobj	_	_
8	this	_	DET	DT	_	9	det	_	_
9	year	_	NOUN	NN	_	4	tmod	_	_
10	.	_	PUNCT	.	_	4	punct	_	_

1	Intense	_	ADJ	JJ	_	2	amod	_	_
2	competition	_	NOUN	NN	_	6	nsubj	_	_
3	,	_	PUNCT	,	_	6	punct	_	_
4	however	_	ADV	RB	_	6	advmod	_	_
5	,	_	PUNCT	,	_	6	punct	_	_
6	led	_	VERB	VBD	_	0	root	_	_
7	to	_	ADP	TO	_	6	prep	_	_
8	unit	_	NOUN	NN	_	10	nn	_	_
9	sales	_	NOUN	NNS	_	10	nn	_	_
10	declines	_	NOUN	NNS	_	7	pobj	_	_
11	for	_	ADP	IN	_	10	prep	_	_
12	a	_	DET	DT	_	13	det	_	_
13	group	_	NOUN	NN	_	11	pobj	_	_
14	of	_	ADP	IN	_	13	prep	_	_
15	Merck	_	PROPN	NNP	_	18	poss	_	_
16	's	_	PART	POS	_	15	possessive	_	_
17	established	_	VERB	VBN	_	18	amod	_	_
18	human	_	NOUN	NN	_	14	pobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	animal-health	_	NOUN	NN	_	21	nn	_	_
21	products	_	NOUN	NNS	_	18	conj	_	_
22	,	_	PUNCT	,	_	13	punct	_	_
23	including	_	VERB	VBG	_	13	prep	_	_
24	Aldomet	_	PROPN	NNP	_	23	pobj	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	Indocin	_	PROPN	NNP	_	24	conj	_	_
27	.	_	PUNCT	.	_	6	punct	_	_

1	In	_	ADP	IN	_	12	prep	_	_
2	New	_	PROPN	NNP	_	7	nn	_	_
3	York	_	PROPN	NNP	_	7	nn	_	_
4	Stock	_	PROPN	NNP	_	7	nn	_	_
5	Exchange	_	PROPN	NNP	_	7	nn	_	_
6	composite	_	ADJ	JJ	_	7	amod	_	_
7	trading	_	NOUN	NN	_	1	pobj	_	_
8	yesterday	_	NOUN	NN	_	12	tmod	_	_
9	,	_	PUNCT	,	_	12	punct	_	_
10	Merck	_	NOUN	NN	_	11	nn	_	_
11	shares	_	NOUN	NNS	_	12	nsubj	_	_
12	closed	_	VERB	VBD	_	0	root	_	_
13	at	_	ADP	IN	_	12	prep	_	_
14	$	_	SYM	$	_	13	pobj	_	_
15	75.25	_	NUM	CD	_	14	num	_	_
16	,	_	PUNCT	,	_	12	punct	_	_
17	up	_	ADP	IN	_	12	advmod	_	_
18	50	_	NUM	CD	_	19	num	_	_
19	cents	_	NOUN	NNS	_	17	pobj	_	_
20	.	_	PUNCT	.	_	12	punct	_	_

1	Warner-Lambert	_	PROPN	NNP	_	2	nn	_	_
2	Co	_	PROPN	NNP	_	0	root	_	_
3	.	_	PUNCT	.	_	2	punct	_	_

1	Warner-Lambert	_	PROPN	NNP	_	8	nsubj	_	_
2	,	_	PUNCT	,	_	1	punct	_	_
3	Morris	_	PROPN	NNP	_	4	nn	_	_
4	Plains	_	PROPN	NNP	_	1	appos	_	_
5	,	_	PUNCT	,	_	4	punct	_	_
6	N.J.	_	PROPN	NNP	_	4	appos	_	_
7	,	_	PUNCT	,	_	4	punct	_	_
8	reported	_	VERB	VBD	_	0	root	_	_
9	sales	_	NOUN	NNS	_	8	dobj	_	_
10	that	_	PRON	WDT	_	13	nsubj	_	_
11	were	_	VERB	VBD	_	13	cop	_	_
12	a	_	DET	DT	_	13	det	_	_
13	record	_	NOUN	NN	_	9	rcmod	_	_
14	for	_	ADP	IN	_	13	prep	_	_
15	any	_	DET	DT	_	16	det	_	_
16	quarter	_	NOUN	NN	_	14	pobj	_	_
17	and	_	CONJ	CC	_	13	cc	_	_
18	the	_	DET	DT	_	20	det	_	_
19	eighth	_	ADJ	JJ	_	20	amod	_	_
20	quarter	_	NOUN	NN	_	13	conj	_	_
21	in	_	ADP	IN	_	20	prep	_	_
22	a	_	DET	DT	_	23	det	_	_
23	row	_	NOUN	NN	_	21	pobj	_	_
24	of	_	ADP	IN	_	20	prep	_	_
25	20	_	NUM	CD	_	26	num	_	_
26	%	_	SYM	NN	_	31	num	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	more	_	ADJ	JJR	_	26	conj	_	_
29	per-share	_	ADJ	JJ	_	31	amod	_	_
30	earnings	_	NOUN	NNS	_	31	nn	_	_
31	growth	_	NOUN	NN	_	24	pobj	_	_
32	.	_	PUNCT	.	_	8	punct	_	_

1	Spurred	_	VERB	VBN	_	15	vmod	_	_
2	by	_	ADP	IN	_	1	prep	_	_
3	growth	_	NOUN	NN	_	2	pobj	_	_
4	in	_	ADP	IN	_	3	prep	_	_
5	world-wide	_	ADJ	JJ	_	6	amod	_	_
6	sales	_	NOUN	NNS	_	4	pobj	_	_
7	of	_	ADP	IN	_	6	prep	_	_
8	the	_	DET	DT	_	9	det	_	_
9	company	_	NOUN	NN	_	12	poss	_	_
10	's	_	PART	POS	_	9	possessive	_	_
11	prescription	_	NOUN	NN	_	12	nn	_	_
12	drugs	_	NOUN	NNS	_	7	pobj	_	_
13	,	_	PUNCT	,	_	15	punct	_	_
14	Warner-Lambert	_	PROPN	NNP	_	15	nsubj	_	_
15	said	_	VERB	VBD	_	0	root	_	_
16	1989	_	NUM	CD	_	21	nsubj	_	_
17	will	_	AUX	MD	_	21	aux	_	_
18	be	_	VERB	VB	_	21	cop	_	_
19	the	_	DET	DT	_	21	det	_	_
20	best	_	ADJ	JJS	_	21	amod	_	_
21	year	_	NOUN	NN	_	15	ccomp	_	_
22	in	_	ADP	IN	_	21	prep	_	_
23	its	_	PRON	PRP$	_	24	poss	_	_
24	history	_	NOUN	NN	_	22	pobj	_	_
25	,	_	PUNCT	,	_	21	punct	_	_
26	with	_	SCONJ	IN	_	29	mark	_	_
27	per-share	_	ADJ	JJ	_	28	amod	_	_
28	earnings	_	NOUN	NNS	_	29	nsubj	_	_
29	expected	_	VERB	VBN	_	21	advcl	_	_
30	to	_	PART	TO	_	31	aux	_	_
31	increase	_	VERB	VB	_	29	xcomp	_	_
32	more	_	ADJ	JJR	_	33	mwe	_	_
33	than	_	ADP	IN	_	34	quantmod	_	_
34	20	_	NUM	CD	_	35	num	_	_
35	%	_	SYM	NN	_	31	dobj	_	_
36	to	_	ADP	TO	_	31	prep	_	_
37	about	_	ADP	IN	_	38	quantmod	_	_
38	$	_	SYM	$	_	36	pobj	_	_
39	6.10	_	NUM	CD	_	38	num	_	_
40	.	_	PUNCT	.	_	15	punct	_	_

1	Sales	_	NOUN	NNS	_	5	nsubj	_	_
2	for	_	ADP	IN	_	1	prep	_	_
3	the	_	DET	DT	_	4	det	_	_
4	quarter	_	NOUN	NN	_	2	pobj	_	_
5	rose	_	VERB	VBD	_	0	root	_	_
6	to	_	ADP	TO	_	5	prep	_	_
7	$	_	SYM	$	_	6	pobj	_	_
8	1.11	_	NUM	CD	_	9	number	_	_
9	billion	_	NUM	CD	_	7	num	_	_
10	from	_	ADP	IN	_	5	prep	_	_
11	$	_	SYM	$	_	10	pobj	_	_
12	1.03	_	NUM	CD	_	13	number	_	_
13	billion	_	NUM	CD	_	11	num	_	_
14	.	_	PUNCT	.	_	5	punct	_	_

1	Prescription-drug	_	NOUN	NN	_	3	nn	_	_
2	world-wide	_	ADJ	JJ	_	3	amod	_	_
3	sales	_	NOUN	NNS	_	4	nsubj	_	_
4	rose	_	VERB	VBD	_	0	root	_	_
5	9	_	NUM	CD	_	6	num	_	_
6	%	_	SYM	NN	_	4	dobj	_	_
7	in	_	ADP	IN	_	4	prep	_	_
8	the	_	DET	DT	_	9	det	_	_
9	quarter	_	NOUN	NN	_	7	pobj	_	_
10	to	_	ADP	TO	_	4	prep	_	_
11	$	_	SYM	$	_	10	pobj	_	_
12	340	_	NUM	CD	_	13	number	_	_
13	million	_	NUM	CD	_	11	num	_	_
14	;	_	PUNCT	:	_	4	punct	_	_
15	U.S.	_	PROPN	NNP	_	16	nn	_	_
16	sales	_	NOUN	NNS	_	17	nsubj	_	_
17	rose	_	VERB	VBD	_	4	parataxis	_	_
18	15	_	NUM	CD	_	19	num	_	_
19	%	_	SYM	NN	_	17	dobj	_	_
20	.	_	PUNCT	.	_	4	punct	_	_

1	The	_	DET	DT	_	2	det	_	_
2	segment	_	NOUN	NN	_	4	poss	_	_
3	's	_	PART	POS	_	2	possessive	_	_
4	growth	_	NOUN	NN	_	6	nsubjpass	_	_
5	was	_	AUX	VBD	_	6	auxpass	_	_
6	led	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	6	prep	_	_
8	sales	_	NOUN	NNS	_	7	pobj	_	_
9	of	_	ADP	IN	_	8	prep	_	_
10	the	_	DET	DT	_	12	det	_	_
11	cardiovascular	_	ADJ	JJ	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	9	pobj	_	_
13	Lopid	_	PROPN	NNP	_	12	dep	_	_
14	,	_	PUNCT	,	_	13	punct	_	_
15	a	_	DET	DT	_	17	det	_	_
16	lipid	_	NOUN	NN	_	17	nn	_	_
17	regulator	_	NOUN	NN	_	13	appos	_	_
18	,	_	PUNCT	,	_	13	punct	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	Dilzem	_	PROPN	NNP	_	13	conj	_	_
21	,	_	PUNCT	,	_	20	punct	_	_
22	a	_	DET	DT	_	25	det	_	_
23	calcium	_	NOUN	NN	_	25	nn	_	_
24	channel	_	NOUN	NN	_	25	nn	_	_
25	blocker	_	NOUN	NN	_	20	appos	_	_
26	.	_	PUNCT	.	_	6	punct	_	_

1	World-wide	_	ADJ	JJ	_	2	amod	_	_
2	sales	_	NOUN	NNS	_	24	nsubj	_	_
3	of	_	ADP	IN	_	2	prep	_	_
4	Warner-Lambert	_	PROPN	NNP	_	8	poss	_	_
5	's	_	PART	POS	_	4	possessive	_	_
6	non-prescription	_	ADJ	JJ	_	8	amod	_	_
7	health-care	_	NOUN	NN	_	8	nn	_	_
8	products	_	NOUN	NNS	_	3	pobj	_	_
9	,	_	PUNCT	,	_	8	punct	_	_
10	such	_	ADJ	JJ	_	11	mwe	_	_
11	as	_	ADP	IN	_	8	prep	_	_
12	Halls	_	PROPN	NNP	_	14	nn	_	_
13	cough	_	NOUN	NN	_	14	nn	_	_
14	tablets	_	NOUN	NNS	_	11	pobj	_	_
15	,	_	PUNCT	,	_	14	punct	_	_
16	Rolaids	_	PROPN	NNP	_	17	nn	_	_
17	antacid	_	NOUN	NN	_	14	conj	_	_
18	,	_	PUNCT	,	_	14	punct	_	_
19	and	_	CONJ	CC	_	14	cc	_	_
20	Lubriderm	_	PROPN	NNP	_	22	nn	_	_
21	skin	_	NOUN	NN	_	22	nn	_	_
22	lotion	_	NOUN	NN	_	14	conj	_	_
23	,	_	PUNCT	,	_	8	punct	_	_
24	increased	_	VERB	VBD	_	0	root	_	_
25	3	_	NUM	CD	_	26	num	_	_
26	%	_	SYM	NN	_	24	dobj	_	_
27	to	_	ADP	TO	_	24	prep	_	_
28	$	_	SYM	$	_	27	pobj	_	_
29	362	_	NUM	CD	_	30	number	_	_
30	million	_	NUM	CD	_	28	num	_	_
31	in	_	ADP	IN	_	24	prep	_	_
32	the	_	DET	DT	_	34	det	_	_
33	third	_	ADJ	JJ	_	34	amod	_	_
34	quarter	_	NOUN	NN	_	31	pobj	_	_
35	;	_	PUNCT	:	_	24	punct	_	_
36	U.S.	_	PROPN	NNP	_	37	nn	_	_
37	sales	_	NOUN	NNS	_	38	nsubj	_	_
38	rose	_	VERB	VBD	_	24	parataxis	_	_
39	5	_	NUM	CD	_	40	num	_	_
40	%	_	SYM	NN	_	38	dobj	_	_
41	.	_	PUNCT	.	_	24	punct	_	_

1	Confectionery	_	ADJ	JJ	_	3	amod	_	_
2	products	_	NOUN	NNS	_	3	nn	_	_
3	sales	_	NOUN	NNS	_	5	nsubj	_	_
4	also	_	ADV	RB	_	5	advmod	_	_
5	had	_	VERB	VBD	_	0	root	_	_
6	strong	_	ADJ	JJ	_	7	amod	_	_
7	growth	_	NOUN	NN	_	5	dobj	_	_
8	in	_	ADP	IN	_	5	prep	_	_
9	the	_	DET	DT	_	10	det	_	_
10	quarter	_	NOUN	NN	_	8	pobj	_	_
11	.	_	PUNCT	.	_	5	punct	_	_

1	World-wide	_	ADJ	JJ	_	2	amod	_	_
2	sales	_	NOUN	NNS	_	18	nsubj	_	_
3	of	_	ADP	IN	_	2	prep	_	_
4	Trident	_	PROPN	NNP	_	5	nn	_	_
5	gum	_	NOUN	NN	_	3	pobj	_	_
6	,	_	PUNCT	,	_	5	punct	_	_
7	Certs	_	PROPN	NNP	_	9	nn	_	_
8	breath	_	NOUN	NN	_	9	nn	_	_
9	mints	_	NOUN	NNS	_	5	conj	_	_
10	,	_	PUNCT	,	_	5	punct	_	_
11	and	_	CONJ	CC	_	5	cc	_	_
12	Clorets	_	PROPN	NNP	_	13	nn	_	_
13	gum	_	NOUN	NN	_	5	conj	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	breath	_	NOUN	NN	_	16	nn	_	_
16	mints	_	NOUN	NNS	_	13	conj	_	_
17	,	_	PUNCT	,	_	5	punct	_	_
18	increased	_	VERB	VB	_	0	root	_	_
19	12	_	NUM	CD	_	20	num	_	_
20	%	_	SYM	NN	_	18	dobj	_	_
21	to	_	ADP	TO	_	18	prep	_	_
22	$	_	SYM	$	_	21	pobj	_	_
23	277	_	NUM	CD	_	24	number	_	_
24	million	_	NUM	CD	_	22	num	_	_
25	.	_	PUNCT	.	_	18	punct	_	_

1	Warner-Lambert	_	PROPN	NNP	_	2	nn	_	_
2	shares	_	NOUN	NNS	_	3	nsubj	_	_
3	closed	_	VERB	VBD	_	0	root	_	_
4	at	_	ADP	IN	_	3	prep	_	_
5	$	_	SYM	$	_	4	pobj	_	_
6	109.50	_	NUM	CD	_	5	num	_	_
7	a	_	DET	DT	_	8	det	_	_
8	share	_	NOUN	NN	_	5	npadvmod	_	_
9	,	_	PUNCT	,	_	3	punct	_	_
10	up	_	ADP	IN	_	3	advmod	_	_
11	$	_	SYM	$	_	10	pobj	_	_
12	1.50	_	NUM	CD	_	11	num	_	_
13	,	_	PUNCT	,	_	3	punct	_	_
14	in	_	ADP	IN	_	3	prep	_	_
15	Big	_	PROPN	NNP	_	18	nn	_	_
16	Board	_	PROPN	NNP	_	18	nn	_	_
17	composite	_	ADJ	JJ	_	18	amod	_	_
18	trading	_	NOUN	NN	_	14	pobj	_	_
19	yesterday	_	NOUN	NN	_	3	tmod	_	_
20	.	_	PUNCT	.	_	3	punct	_	_

1	Eli	_	PROPN	NNP	_	2	nn	_	_
2	Lilly	_	PROPN	NNP	_	0	root	_	_
3	&	_	CONJ	CC	_	2	cc	_	_
4	Co	_	PROPN	NNP	_	2	conj	_	_
5	.	_	PUNCT	.	_	4	punct	_	_

1	Lilly	_	PROPN	NNP	_	2	nsubj	_	_
2	attributed	_	VERB	VBD	_	0	root	_	_
3	record	_	NOUN	NN	_	4	npadvmod	_	_
4	third-quarter	_	ADJ	JJ	_	2	dobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	nine-month	_	ADJ	JJ	_	7	amod	_	_
7	results	_	NOUN	NNS	_	4	conj	_	_
8	to	_	ADP	TO	_	2	prep	_	_
9	world-wide	_	ADJ	JJ	_	10	amod	_	_
10	gains	_	NOUN	NNS	_	8	pobj	_	_
11	for	_	ADP	IN	_	10	prep	_	_
12	pharmaceuticals	_	NOUN	NNS	_	11	pobj	_	_
13	,	_	PUNCT	,	_	12	punct	_	_
14	medical	_	ADJ	JJ	_	15	amod	_	_
15	instruments	_	NOUN	NNS	_	12	conj	_	_
16	and	_	CONJ	CC	_	12	cc	_	_
17	plant-science	_	NOUN	NN	_	18	nn	_	_
18	products	_	NOUN	NNS	_	12	conj	_	_
19	despite	_	ADP	IN	_	10	prep	_	_
20	poor	_	ADJ	JJ	_	22	amod	_	_
21	exchange	_	NOUN	NN	_	22	nn	_	_
22	rates	_	NOUN	NNS	_	19	pobj	_	_
23	for	_	ADP	IN	_	22	prep	_	_
24	the	_	DET	DT	_	25	det	_	_
25	dollar	_	NOUN	NN	_	23	pobj	_	_
26	that	_	PRON	WDT	_	27	nsubj	_	_
27	slowed	_	VERB	VBD	_	22	rcmod	_	_
28	sales	_	NOUN	NNS	_	27	dobj	_	_
29	abroad	_	ADV	RB	_	28	advmod	_	_
30	.	_	PUNCT	.	_	2	punct	_	_

1	Earnings	_	NOUN	NNS	_	2	nsubj	_	_
2	continued	_	VERB	VBD	_	0	root	_	_
3	to	_	PART	TO	_	4	aux	_	_
4	pace	_	VERB	VB	_	2	xcomp	_	_
5	sales	_	NOUN	NNS	_	4	dobj	_	_
6	because	_	ADP	IN	_	7	mwe	_	_
7	of	_	ADP	IN	_	2	prep	_	_
8	a	_	DET	DT	_	11	det	_	_
9	lower	_	ADJ	JJR	_	11	amod	_	_
10	tax	_	NOUN	NN	_	11	nn	_	_
11	rate	_	NOUN	NN	_	7	pobj	_	_
12	,	_	PUNCT	,	_	11	punct	_	_
13	profit	_	NOUN	NN	_	11	conj	_	_
14	from	_	ADP	IN	_	13	prep	_	_
15	the	_	DET	DT	_	16	det	_	_
16	renegotiation	_	NOUN	NN	_	14	pobj	_	_
17	of	_	ADP	IN	_	16	prep	_	_
18	the	_	DET	DT	_	20	det	_	_
19	debt	_	NOUN	NN	_	20	nn	_	_
20	instrument	_	NOUN	NN	_	17	pobj	_	_
21	received	_	VERB	VBN	_	20	vmod	_	_
22	from	_	ADP	IN	_	21	prep	_	_
23	Faberge	_	PROPN	NNP	_	24	nn	_	_
24	Inc.	_	PROPN	NNP	_	22	pobj	_	_
25	in	_	ADP	IN	_	21	prep	_	_
26	connection	_	NOUN	NN	_	25	pobj	_	_
27	with	_	ADP	IN	_	26	prep	_	_
28	Lilly	_	PROPN	NNP	_	30	poss	_	_
29	's	_	PART	POS	_	28	possessive	_	_
30	sale	_	NOUN	NN	_	27	pobj	_	_
31	of	_	ADP	IN	_	30	prep	_	_
32	Elizabeth	_	PROPN	NNP	_	34	nn	_	_
33	Arden	_	PROPN	NNP	_	34	nn	_	_
34	Inc.	_	PROPN	NNP	_	31	pobj	_	_
35	in	_	ADP	IN	_	30	prep	_	_
36	1987	_	NUM	CD	_	35	pobj	_	_
37	,	_	PUNCT	,	_	11	punct	_	_
38	and	_	CONJ	CC	_	11	cc	_	_
39	net	_	ADJ	JJ	_	40	amod	_	_
40	proceeds	_	NOUN	NNS	_	11	conj	_	_
41	from	_	ADP	IN	_	40	prep	_	_
42	the	_	DET	DT	_	43	det	_	_
43	settlement	_	NOUN	NN	_	41	pobj	_	_
44	of	_	ADP	IN	_	43	prep	_	_
45	patent	_	NOUN	NN	_	46	nn	_	_
46	litigation	_	NOUN	NN	_	44	pobj	_	_
47	at	_	ADP	IN	_	43	prep	_	_
48	Lilly	_	PROPN	NNP	_	52	poss	_	_
49	's	_	PART	POS	_	48	possessive	_	_
50	Hybritech	_	PROPN	NNP	_	52	nn	_	_
51	Inc.	_	PROPN	NNP	_	52	nn	_	_
52	unit	_	NOUN	NN	_	47	pobj	_	_
53	.	_	PUNCT	.	_	2	punct	_	_

1	Third-quarter	_	NOUN	NN	_	2	nn	_	_
2	sales	_	NOUN	NNS	_	10	nsubj	_	_
3	of	_	ADP	IN	_	2	prep	_	_
4	the	_	DET	DT	_	9	det	_	_
5	Indianapolis	_	PROPN	NNP	_	9	dep	_	_
6	,	_	PUNCT	,	_	5	punct	_	_
7	Ind.	_	PROPN	NNP	_	5	dep	_	_
8	,	_	PUNCT	,	_	5	punct	_	_
9	company	_	NOUN	NN	_	3	pobj	_	_
10	rose	_	VERB	VBD	_	0	root	_	_
11	11	_	NUM	CD	_	12	num	_	_
12	%	_	SYM	NN	_	10	dobj	_	_
13	to	_	ADP	TO	_	10	prep	_	_
14	$	_	SYM	$	_	13	pobj	_	_
15	1.045	_	NUM	CD	_	16	number	_	_
16	billion	_	NUM	CD	_	14	num	_	_
17	from	_	ADP	IN	_	10	prep	_	_
18	$	_	SYM	$	_	17	pobj	_	_
19	940.6	_	NUM	CD	_	20	number	_	_
20	million	_	NUM	CD	_	18	num	_	_
21	.	_	PUNCT	.	_	10	punct	_	_

1	Nine-month	_	ADJ	JJ	_	2	amod	_	_
2	sales	_	NOUN	NNS	_	3	nsubj	_	_
3	grew	_	VERB	VBD	_	0	root	_	_
4	12	_	NUM	CD	_	5	num	_	_
5	%	_	SYM	NN	_	3	dobj	_	_
6	to	_	ADP	TO	_	3	prep	_	_
7	$	_	SYM	$	_	6	pobj	_	_
8	3.39	_	NUM	CD	_	9	number	_	_
9	billion	_	NUM	CD	_	7	num	_	_
10	from	_	ADP	IN	_	3	prep	_	_
11	$	_	SYM	$	_	10	pobj	_	_
12	3.03	_	NUM	CD	_	13	number	_	_
13	billion	_	NUM	CD	_	11	num	_	_
14	a	_	DET	DT	_	15	det	_	_
15	year	_	NOUN	NN	_	16	npadvmod	_	_
16	earlier	_	ADV	RBR	_	10	advmod	_	_
17	.	_	PUNCT	.	_	3	punct	_	_

1	Sales	_	NOUN	NNS	_	8	nsubj	_	_
2	of	_	ADP	IN	_	1	prep	_	_
3	Prozac	_	PROPN	NNP	_	2	pobj	_	_
4	,	_	PUNCT	,	_	3	punct	_	_
5	an	_	DET	DT	_	6	det	_	_
6	anti-depressant	_	NOUN	NN	_	3	appos	_	_
7	,	_	PUNCT	,	_	3	punct	_	_
8	led	_	VERB	VBD	_	0	root	_	_
9	drug-sales	_	NOUN	NNS	_	10	nn	_	_
10	increases	_	NOUN	NNS	_	8	dobj	_	_
11	.	_	PUNCT	.	_	8	punct	_	_

1	Higher	_	ADJ	JJR	_	2	amod	_	_
2	sales	_	NOUN	NNS	_	11	nsubj	_	_
3	of	_	ADP	IN	_	2	prep	_	_
4	pesticides	_	NOUN	NNS	_	3	pobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	other	_	ADJ	JJ	_	8	amod	_	_
7	plant-science	_	NOUN	NN	_	8	nn	_	_
8	products	_	NOUN	NNS	_	4	conj	_	_
9	more	_	ADV	RBR	_	10	advmod	_	_
10	than	_	ADP	IN	_	11	advmod	_	_
11	offset	_	VERB	VBP	_	32	ccomp	_	_
12	a	_	DET	DT	_	14	det	_	_
13	slight	_	ADJ	JJ	_	14	amod	_	_
14	decline	_	NOUN	NN	_	11	dobj	_	_
15	in	_	ADP	IN	_	14	prep	_	_
16	the	_	DET	DT	_	17	det	_	_
17	sales	_	NOUN	NNS	_	15	pobj	_	_
18	of	_	ADP	IN	_	17	prep	_	_
19	animal-health	_	NOUN	NN	_	20	nn	_	_
20	products	_	NOUN	NNS	_	18	pobj	_	_
21	to	_	PART	TO	_	22	aux	_	_
22	fuel	_	VERB	VB	_	11	vmod	_	_
23	the	_	DET	DT	_	24	det	_	_
24	increase	_	NOUN	NN	_	22	dobj	_	_
25	in	_	ADP	IN	_	24	prep	_	_
26	world-wide	_	ADJ	JJ	_	29	amod	_	_
27	agricultural	_	ADJ	JJ	_	29	amod	_	_
28	product	_	NOUN	NN	_	29	nn	_	_
29	sales	_	NOUN	NNS	_	25	pobj	_	_
30	,	_	PUNCT	,	_	32	punct	_	_
31	Lilly	_	PROPN	NNP	_	32	nsubj	_	_
32	said	_	VERB	VBD	_	0	root	_	_
33	.	_	PUNCT	.	_	32	punct	_	_

1	Advanced	_	PROPN	NNP	_	4	nn	_	_
2	Cardiovascular	_	PROPN	NNP	_	4	nn	_	_
3	Systems	_	PROPN	NNPS	_	4	nn	_	_
4	Inc.	_	PROPN	NNP	_	10	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	Cardiac	_	PROPN	NNP	_	9	nn	_	_
7	Pacemakers	_	PROPN	NNPS	_	9	nn	_	_
8	Inc.	_	PROPN	NNP	_	9	nn	_	_
9	units	_	NOUN	NNS	_	4	conj	_	_
10	led	_	VERB	VBD	_	0	root	_	_
11	growth	_	NOUN	NN	_	10	dobj	_	_
12	in	_	ADP	IN	_	11	prep	_	_
13	the	_	DET	DT	_	16	det	_	_
14	medical-instrument	_	ADJ	JJ	_	16	amod	_	_
15	systems	_	NOUN	NNS	_	16	nn	_	_
16	division	_	NOUN	NN	_	12	pobj	_	_
17	.	_	PUNCT	.	_	10	punct	_	_

1	Lilly	_	PROPN	NNP	_	2	nn	_	_
2	shares	_	NOUN	NNS	_	3	nsubj	_	_
3	closed	_	VERB	VBD	_	0	root	_	_
4	yesterday	_	NOUN	NN	_	3	tmod	_	_
5	in	_	ADP	IN	_	3	prep	_	_
6	composite	_	ADJ	JJ	_	7	amod	_	_
7	trading	_	NOUN	NN	_	5	pobj	_	_
8	on	_	ADP	IN	_	7	prep	_	_
9	the	_	DET	DT	_	11	det	_	_
10	Big	_	PROPN	NNP	_	11	nn	_	_
11	Board	_	PROPN	NNP	_	8	pobj	_	_
12	at	_	ADP	IN	_	3	prep	_	_
13	$	_	SYM	$	_	12	pobj	_	_
14	62.25	_	NUM	CD	_	13	num	_	_
15	,	_	PUNCT	,	_	3	punct	_	_
16	down	_	ADP	IN	_	3	advmod	_	_
17	12.5	_	NUM	CD	_	18	num	_	_
18	cents	_	NOUN	NNS	_	16	pobj	_	_
19	.	_	PUNCT	.	_	3	punct	_	_

